宁科生物
(600165)
| 流通市值：24.55亿 | | | 总市值：54.13亿 |
| 流通股本：7.33亿 | | | 总股本：16.16亿 |
| 报告期 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 流动资产: | | | | |
| 货币资金 | 189,970,617.23 | 272,493,014.61 | 460,649,079.29 | 8,366,470.09 |
| 应收票据及应收账款 | 124,067,645.7 | 117,899,385.7 | 108,302,571.58 | 120,057,899.01 |
| 其中：应收票据 | 4,909,222.3 | 2,725,862.51 | 9,278,184.97 | - |
| 应收账款 | 119,158,423.4 | 115,173,523.19 | 99,024,386.61 | 120,057,899.01 |
| 应收款项融资 | 5,481,469.6 | 510,177.85 | 2,082,239 | 11,891,462.63 |
| 预付款项 | 11,087,849.75 | 24,932,612.63 | 9,853,158.67 | 25,289,627.99 |
| 其他应收款合计 | 37,851,652.03 | 87,442,298 | 37,305,085.36 | 5,783,084.38 |
| 存货 | 177,504,434.9 | 173,018,132.72 | 117,279,323.33 | 126,948,969.28 |
| 其他流动资产 | 66,281,351.24 | 35,665,476.42 | 56,296,370.04 | 19,205,806.2 |
| 流动资产合计 | 612,245,020.45 | 711,961,097.93 | 791,767,827.27 | 317,543,319.58 |
| 非流动资产: | | | | |
| 投资性房地产 | 3,929,434.53 | 3,963,614.25 | 8,289,243.85 | 63,357,155.2 |
| 固定资产 | 1,495,623,265.2 | 1,513,441,286.5 | 1,537,333,836.81 | 1,642,023,298.89 |
| 在建工程 | 128,811,903.19 | 99,867,370.23 | 81,385,062.09 | 106,997,528.38 |
| 使用权资产 | 1,123,190.35 | 979,250.9 | 1,043,939.32 | 1,259,083.91 |
| 无形资产 | 58,794,323.28 | 59,322,602.27 | 60,267,887.8 | 64,117,690.97 |
| 开发支出 | - | - | - | 1,287,332.31 |
| 长期待摊费用 | 3,422,202.51 | 3,613,086.03 | 3,803,969.56 | 4,430,186.99 |
| 递延所得税资产 | 2,219,722.98 | 2,139,565.66 | 2,158,988.35 | 4,714,368.02 |
| 其他非流动资产 | 35,151,574.88 | 10,300,303.09 | 4,002,477.71 | 20,328,169.51 |
| 非流动资产合计 | 1,729,075,616.92 | 1,693,627,078.93 | 1,698,285,405.49 | 1,908,514,814.18 |
| 资产总计 | 2,341,320,637.37 | 2,405,588,176.86 | 2,490,053,232.76 | 2,226,058,133.76 |
| 流动负债: | | | | |
| 短期借款 | 10,000,000 | 7,211,800 | 7,814,300 | 218,320,269.59 |
| 应付票据及应付账款 | 143,140,602.45 | 118,600,124.44 | 115,962,000.72 | 832,704,981.55 |
| 应付账款 | 143,140,602.45 | 118,600,124.44 | 115,962,000.72 | 832,704,981.55 |
| 预收款项 | - | - | 0 | - |
| 合同负债 | 4,009,207.28 | 4,724,500.49 | 3,297,326.05 | 4,627,273.28 |
| 应付职工薪酬 | 2,419,302.84 | 2,330,000.74 | 14,642,562.42 | 46,090,640.82 |
| 应交税费 | 5,030,100 | 7,994,435.65 | 14,494,150.63 | 11,641,519.97 |
| 其他应付款合计 | 94,758,415.43 | 119,398,053.02 | 126,300,188.84 | 512,380,899.59 |
| 其中:应付利息 | - | - | - | 89,732,379.47 |
| 一年内到期的非流动负债 | 2,529,389.58 | 2,635,923.83 | 2,664,028.18 | 1,272,488.56 |
| 其他流动负债 | 417,786.47 | 300,178.97 | 450,966.8 | 368,170,908.95 |
| 流动负债合计 | 262,304,804.05 | 263,195,017.14 | 285,625,523.64 | 1,995,208,982.31 |
| 非流动负债: | | | | |
| 长期借款 | - | - | - | 250,000,000 |
| 租赁负债 | 693,546.78 | - | 901,789.04 | 1,325,177.59 |
| 长期应付款 | 853,271,116.1 | 851,420,511.96 | 848,208,160.3 | - |
| 预计负债 | - | - | - | 1,566,401.3 |
| 递延收益 | 19,585,905.65 | 16,832,038.16 | 17,262,939.69 | 17,270,271.6 |
| 递延所得税负债 | 1,841,041.94 | 1,931,941.44 | 2,034,728.58 | 2,199,796.04 |
| 非流动负债合计 | 875,391,610.47 | 870,184,491.56 | 868,407,617.61 | 272,361,646.53 |
| 负债合计 | 1,137,696,414.52 | 1,133,379,508.7 | 1,154,033,141.25 | 2,267,570,628.84 |
| 所有者权益(或股东权益): | | | | |
| 实收资本(或股本) | 1,615,883,775 | 1,615,883,775 | 1,615,883,775 | 684,883,775 |
| 资本公积 | 1,253,269,719.04 | 1,253,269,719.04 | 1,253,269,719.04 | 957,739,976.24 |
| 盈余公积 | 31,502,847.56 | 31,502,847.56 | 31,502,847.56 | 31,502,847.56 |
| 未分配利润 | -1,825,178,804.99 | -1,757,025,530.91 | -1,692,709,997.77 | -1,853,312,318.5 |
| 归属于母公司股东权益合计 | 1,075,477,536.61 | 1,143,630,810.69 | 1,207,946,343.83 | -179,185,719.7 |
| 少数股东权益 | 128,146,686.24 | 128,577,857.47 | 128,073,747.68 | 137,673,224.62 |
| 股东权益合计 | 1,203,624,222.85 | 1,272,208,668.16 | 1,336,020,091.51 | -41,512,495.08 |
| 负债和股东权益合计 | 2,341,320,637.37 | 2,405,588,176.86 | 2,490,053,232.76 | 2,226,058,133.76 |
| 公告日期 | 2026-08-29 | 2026-04-30 | 2026-04-24 | 2025-10-31 |
| 审计意见(境内) | | | 带强调事项段的无保留意见 | |